Axitinib (AG-013736) in patients with metastatic melanoma: A phase II study

Title
Axitinib (AG-013736) in patients with metastatic melanoma: A phase II study
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL ONCOLOGY
Volume 26, Issue 15_suppl, Pages 9006-9006
Publisher
American Society of Clinical Oncology (ASCO)
Online
2017-02-24
DOI
10.1200/jco.2008.26.15_suppl.9006

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation